INMD
InMode LtdNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$817.88M
P/E Ratio
9.96
EPS
$1.35
Beta
1.93
52W High
$16.74
52W Low
$12.72
50-Day MA
$13.95
200-Day MA
$14.40
Dividend Yield
—
Profit Margin
23.30%
Forward P/E
9.99
PEG Ratio
2.90
About InMode Ltd
InMode Ltd. designs, develops, manufactures and markets minimally invasive aesthetic medical products based on its proprietary RF-assisted lipolysis and deep subdermal fractional RF technologies. The company is headquartered in Yokneam, Israel.
Fundamentals
| Revenue (TTM) | $374.64M |
| Gross Profit (TTM) | $291.61M |
| EBITDA | $80.52M |
| Operating Margin | 12.30% |
| Return on Equity | 13.60% |
| Return on Assets | 6.86% |
| Revenue/Share (TTM) | $5.92 |
| Book Value | $10.78 |
| Price-to-Book | 1.29 |
| Price-to-Sales (TTM) | 2.18 |
| EV/Revenue | 0.861 |
| EV/EBITDA | 4.00 |
| Quarterly Earnings Growth (YoY) | -30.80% |
| Quarterly Revenue Growth (YoY) | 5.30% |
| Shares Outstanding | $60.81M |
| Float | $53.89M |
| % Insiders | 11.92% |
| % Institutions | 54.24% |
Historical Volatility
HV 10-Day
14.42%
HV 20-Day
15.51%
HV 30-Day
23.22%
HV 60-Day
23.25%
HV Rank
12.7%
Volatility is currently contracting
Analyst Ratings
Consensus ($14.33 target)
5
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026